Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1995-06-07
1999-02-02
Housel, James C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
4242341, 4242431, 530395, 530403, 530405, A61K 39385
Patent
active
058661328
ABSTRACT:
The invention provides immunogenic oligosaccharide compositions and methods of making and using them. In particular, the compositions comprise oligosaccharides covalently coupled to carrier protein, wherein the resultant conjugate has been shown to contain specific immunogenic epitopes and elicits a protectively immunogenic response.
REFERENCES:
patent: 4619828 (1986-10-01), Gordon
patent: 4644059 (1987-02-01), Gordon
patent: 4663160 (1987-05-01), Tsay et al.
patent: 4673574 (1987-06-01), Anderson
patent: 4695624 (1987-09-01), Marburg et al.
patent: 4711779 (1987-12-01), Prro
patent: 4771127 (1988-09-01), Cryz et al.
patent: 4882317 (1989-11-01), Marburg et al.
patent: 5153312 (1992-10-01), Porro
Verheul et al. Mar. 1991, Infection & Immun. 59(3):843-851.
Anderson et al. Jul. 1985, J. Clin. Invest. 76:52-59.
Svenson et al. 1979. J. Immunol. Methods. 25:323 -335.
Paoletti, L. C. et al., "Effects of Chain Length on the Immunogenicity in Rabbits of Group B Streptococcus Type III Oligosaccharide-Tetanus Toxoid Conjugates", The Journal of Clinical Investigation, 89:203-209 (1992).
PCT Search Report mailed Oct. 4, 1996.
Paoletti, L. et al., "Group B Streptococcus Type II Polysaccharide-Tetanus Toxoid Conjugate Vaccine," Infection and Immunity, 60(10):4009-14 (Oct. 1992).
Lee, C. et al., "Pneumococcal Infection and Immunization in Children," Critical Reviews in Microbiology, 20(1):1-12 (1994).
Steinhoff, M. et al., "A Randomized Comparison of Three Bivalent Streptococcus Pneumoniae Glycoprotein Conjugate Vaccines in Young Children: Effect of Polysaccharide Size and Linkage Characteristics," Pediatr. Infect Dis. J., 13:368-372 (1994).
Peeters, C. et al., "Pneumococcal Conjugate Vaccines," Immunology Letters, 30:267-274 (1991).
De Velasco E. et al., "Epitope Specificity of Rabbit Immunoglobulin G (lgG) Elicited by Pneumococcal Type 23F Synthetic Oligosaccharide-and Native Polysaccharide -Protein Conjugate Vaccines: Comparison with Human Anti-Polysaccharide 23F lgG," Infection and Immunity, 62(3):799-808 (Mar. 1994).
Malcolm, A. et al., "Improved Conjugate Vaccines," Journal of Cellular Biochemistry, Supplement 17C, Feb. 8 -Mar. 14, 1993.
Anderson, P., "Antibody Responses to Haemophilus influenzae Type b and Diphtheria Toxin Induced by Conjugates of Oligosaccharides of the Type b Capsule with the Nontoxic Protein CRM.sub.197 " Infect. Immun. 39:233-238 (1983).
Anderson, P. et al., "Immunogenes Consisting of Oligosaccharides from the Capsule of Haemophilus influenzae Type b Coupled to Diphtheria Toxoid or the Toxin Protein CRM.sub.197 " J. Clin. Invest. 76:52-59 (1985).
Anderson, P. et al., "Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b" Journal of Pediatrics 107:346-351 (1985).
Anderson, P. et al., "Vaccines Consisting of Periodate-Cleaved Oligosaccharides from the Capsule of Haemophilus influenzae Type b Coupled to a Protein Carrier: Structural and Temporal Requirements for Priming in the Human Infant" J. of Immunol. 137:1181-1186 (1986).
Anderson, P. et al., "Effect of Oligosaccharide Chain Length, Exposed Terminal Group, and Hapten Loading on the Antibody Response of Human Adults and Infants to Vaccines Consisting of Haemophilus influenzae Type b Capsular Antigen Uniterminally Coupled to the Diphtheria Protein CRM.sub.197 " J. of Immunol. 142: 2464-2468 (1989).
Avery, O.T et al., "Chemo-Immunological Studies on Conjugated Carbohydrate-Proteins" J. Exp. Med. 50:533-550 (1929).
Barra, A. et al., "Characterization of the Serum Antibody Response Induced by Haemophilus influenzae Type b Tetanus Protein-Conjugate Vaccine in Infants Receiving a DTP-Combined Vaccine from 2 Months of Age" Vaccine 11:1003-1006 (1993).
Bhattacharjee, A.K. et al., "Structural Determination of the Sialic Acid Polysaccharide Antigens of Neisseria meningitidis Serogroups B and C with Carbon 13 Nuclear Magnetic Resonance" Journal of Biological Chemistry 250(5):1926-1932 (1975).
Bixler, G.S. et al., "The Cellular Basis of the Immune Response to Conjugate Vaccines" Contrib. Microbiol. Immunol., J. M. Cruse and R. E. Lewis, eds., 10: 18-47 (1989).
Bolan, G. et al., "Pneumococcal Vaccine Efficacy in Selected Populations in the United States" Ann. Internal Med. 104(1):1-6 (1986).
Borgono, J. M. et al., "Vaccination and Revaccination with Polyvalent Pneumococcal Polysaccharide Vaccines in Adults and Infants (40010)" Proc. Soc. Exp. Biol. Med. 157:148-154 (1978).
Broome, C.V. et al., "Pneumococcal Disease After Pneumococcal Vaccination" New Eng. J. Med. 303(10): 549-552 (1980).
Bruyn, G.A.W. et al., "Pneumococcal Polysaccharide Vaccines: Indications, Efficacy and Recommendations"Eur. J. Clin. Microbiol. Infect. Dis. 10:897-910 (1991).
Chudwin, D.S. et al., "Correlation of Serum Opsonins with In Vitro Phagocytosis of Streptococcus pneumoniae" Infect. Immun. 50:213-217 (1985).
Connelly, K.K. et al., "Vaccine-Preventable Respiratory Infections in Childhood" Seminars in Respiratory Infections 6(4): 204-216 (1991).
Cruse, J.M. et al., "Contemporary Trends in Conjugate Vaccine Development" Contrib. Microbiol. Immunol., J. M. Cruse and Re. E. Lewis, eds., 10:1-10 (1989).
Eby, R. et al., "Pneumococcal Conjugate Vaccines" in Modern Approaches to New Vaccines Including Prevention of AIDS, E. Norby, F. Brown and C. Chanock (eds.) (1994).
Fattom, A. et al., "Serum Antibody Response in Adult Volunteers Elicited by Injection of Streptococcus pneumoniae Type 12F Polysaccharide Alone or Conjugated to Diphtheria Toxoid" Infect. Immun .58(7):2309-2312 (1990).
Fattom, A. et al., "Synthesis and Physicochemical and Immunological Characterization of Pneumococcus Type 12F Polysaccharide-Diphtheria Toxoid Conjugates" Infect. Immun. 56(9):2292-2298 (1988).
Forrester, H.L. et al., "Inefficacy of Pneumococcal Vaccine in a High-Risk Population" Am. J. Med. 83:425-430 (1987).
Garner, C.V. et al., "Immunologic Considerations for the Development of Conjugate Vaccines" Contrib. Microbiol. Immunol. J. M. Cruse and R. E. Lewis, eds. 10:11-17 (1989).
Gaur, A. et al., "Bypass by an Alternate 'Carrier' of Acquired Unresponsiveness to hCG Upon Repeated Immunization with Tetanus-Conjugated Vaccine" Int. Immunol. 2(2):151-155 (1990).
Giebink, G. S. et al., "Pneumococcal Capsular Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccines: Immunogenicity and Efficacy in Experimental Pneumococcal Otitis Media" J. Inf. Dis. 167:347-355 (1993).
Goebel, W. F. et al., "Chemo-Immunological Studies on Conjugated Carbohydrate-Proteins" J. Exp. Med. 50:521-531 (1929).
Hakamori, S. et al., "Carbohydrate Antigens in Higher Animals" Handbook of Experimental Immunology 1(Ch. 9):9.1-9.39 (1986).
Hazlewood, M. et al., "The Acquisition of Anti-Pneumococcal Capsular Polysaccharide Haemophilus influenzae Type b and Tetanus Toxoid Antibodies, with Age, in the UK" Clin. Exp. Immunol. 93:157-164 (1993).
Heidelberger, M. et al., "The Soluble Specific Substance of Pneumococcus" J. Exp. Med. 38:73-79 (1929).
Hilleman, M. R. et al., "Streptococcus pneumoniae Polysaccharide Vaccine: Age and Dose Responses, Safety, Persistence of Antibody, Revaccination, and Simultaneous Administration of Pneumococcal and Influenza Vaccines" Reviews of Infectious Diseases 3(Supp.):S31-S42 (1981).
Jennings, H. J. et al., "Structural Determination of the Capsular Polysaccharide of Streptococcus pneumoniae Type-19 (19F)" Can. J. Chem 58:1069-1074 (1980).
Jennings, H. J. et al., "Structure of the Complex Polysaccharide C-Substances from Streptococcus pneumoniae Type 1" Biochemistry 19:4712-4719 (1980).
Jones, J.K.N. et al., "The Structure of the Type VIII Pneumococcus Specific Polysaccharide" J. Am. Chem. Soc. 79:2787-2793 (1957).
Kabat, E. A., "Carbohydrates as Antigens and Immunogens: Size, Shape and Nature of Carbohydrate Epitopes and Idiotopes Polysaccharide Vaccines" R. Bell and G. Torrigiani (eds.), Towards Better Carbohydrate Vaccines, pp. 75-97 (1987).
Kenne, L. et al., "Bacterial Polysaccharides" The Polysaccharides, vol. 2, G. O. Aspinall, Ed., Academic Press, pp. 287-362 (1983).
Kenne, L. et
Alberta Research Council
Housel James C.
Shaver Jennifer
LandOfFree
Immunogenic oligosaccharide compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic oligosaccharide compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic oligosaccharide compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1114642